Kamada Ltd.

KMDA Healthcare Drug Manufacturers Specialty & Generic

Kamada Ltd.’s revenue for fiscal 2025 (year ended December 2025) was $180.5 million, up 12.1% from fiscal 2024. In the quarter to June 2026, revenue grew 22.7%, EPS grew 23.1%, free cash flow grew 165.7% and total debt fell 38.8%, each against the same quarter a year earlier. Revenue growth for three consecutive years.

7.77 0.06 −0.77%
Market cap
$451.7M
P/E
20.4×
Fwd P/E
0.0×
Dividend yield
5.41%
F-score
7/9
Altman Z
3.33
Beneish M
−2.35
Dividend safety
50/100

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Cash and Short Term Investments
75.47 78.44 55.64 34.26 18.59 109.27 73.91 50.59 43.02 28.63
Receivables
32.66 27.09 25.84 35.96 44.03 26.63 26.48 30.98 32.79 22.85
Inventory
84.94 78.82 88.48 68.79 67.42 42.02 43.17 29.32 21.07 25.59
Total current assets
193.08 184.35 169.96 139.01 130.04 177.91 143.56 110.89 96.88 77.08
Property, Plant, Equpment (Net)
41.37 36.25 28.22 26.16 26.31 25.68 24.55 25.00 25.18 22.58
Goodwill and Intangible Assets (Total)
30.31 30.31 30.31 147.44 154.19 1.56 0.29 0.00 — 0.33
Long Term Assets (Tax, Deferred)
— 0.49 — — — — 1.31 2.05 — —
Long-term assets (Other)
105.06 111.25 118.65 154.65 159.22 3.63 0.35 0.17 0.05 0.04
Total non-current assets
185.64 187.91 184.95 183.37 188.62 32.75 30.24 27.23 25.23 22.62
Total Assets
378.71 372.26 354.91 322.38 318.67 210.67 173.80 138.12 122.11 99.70
Accounts Payable
35.35 37.41 33.07 40.50 32.25 23.66 30.64 22.55 23.86 21.89
Current Part of Debt
9.92 10.18 15.00 34.15 20.62 0.24 0.49 0.45 0.61 0.41
Current Revenue (Deferred)
— 0.17 0.15 0.04 0.04 — 0.59 0.46 4.93 4.90
Total current liabilities
47.39 49.39 49.59 75.71 54.06 24.97 32.74 23.57 29.40 27.21
Long Term Debt (Total)
— — — 12.96 17.41 0.04 0.26 0.69 1.37 1.36
Non-current Revenue (Deferred)
— — — — 0.02 2.03 0.23 0.67 0.71 3.66
Pension and Post-Retirement Liabilities
0.67 0.51 0.62 0.67 1.28 1.41 1.27 0.79 1.14 0.72
Long Term Tax Liability (Deferred)
1.65 — — — — 1.42 (1.45) (2.13) — —
Non-current Liabilities (Other)
50.49 53.46 53.23 54.84 65.92 1.56 1.16 0.80 1.14 0.72
Total non-current liabilities
62.25 63.40 61.29 70.65 87.79 7.06 5.74 2.17 3.22 5.75
Total liabilities
109.64 112.79 110.89 146.36 141.84 32.03 38.48 25.74 32.62 32.95
Additional Paid In Capital
268.28 266.93 265.85 210.50 210.20 209.76 180.82 179.15 177.87 162.67
Common Stock (Net)
15.08 15.03 15.02 11.73 11.73 11.71 10.43 10.41 10.40 9.32
Retained Earnings
(17.07) (25.74) (40.20) (48.48) (46.16) (43.93) (61.07) (83.02) (104.56) (111.46)
Shareholders Equity (Other)
2.78 3.24 3.35 2.28 1.06 1.11 5.15 5.84 5.78 6.22
Common Equity (Total)
269.07 259.46 244.02 176.02 176.82 178.64 135.32 112.38 89.49 66.74
Shareholders Equity (Total)
269.07 259.46 244.02 176.02 176.82 178.64 135.32 112.38 89.49 66.74
Shareholders Equity and Liabilities (Total)
378.71 372.26 354.91 322.38 318.67 210.67 173.80 138.12 122.11 99.70
Shares (Common)
57.69 57.51 57.48 44.83 44.80 44.74 40.35 40.30 40.26 36.42
Shareholders Equity (Tangible)
238.76 229.15 213.71 176.02 176.82 178.64 135.32 112.38 89.49 66.74
Net Debt
(65.55) (68.25) (40.64) 12.86 19.44 (108.99) (73.16) (49.45) (41.03) (26.86)
Total Debt
9.92 10.18 15.00 47.12 38.02 0.27 0.75 1.14 1.98 1.78

Fold the line items

In millions of $ except per-share values · columns are period end dates